Arthritis · Denver area, CO
Arthritis studies in Denver area, CO
18 recruiting studies have a site in the Denver area. This page includes nearby cities such as Aurora, Lakewood, Englewood, Littleton.
18 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Denver, CO + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 1/Phase 2
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Bristol-Myers Squibb
- Location
- Denver, CO
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
Medipost, Inc.
- Location
- Parker, CO + 33 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With…
Amgen
- Location
- Denver, CO + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Denver, CO + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
Phase 1b/2 Study of IV Sarilumab in Adult With RA
Sanofi
- Location
- Centennial, CO + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
AstraZeneca
- Location
- Aurora, CO + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Amgen
- Location
- Aurora, CO + 12 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Crystalys Therapeutics
- Location
- Denver, CO + 81 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Crystalys Therapeutics
- Location
- Denver, CO + 82 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Crystalys Therapeutics
- Location
- Denver, CO + 40 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Takeda
- Location
- Denver, CO + 18 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Clinical Outcomes Study of the Nexel Total Elbow
Zimmer Biomet
- Location
- Golden, CO + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Sonoma Biotherapeutics, Inc.
- Location
- Aurora, CO + 8 other US sites
- Eligibility basics
- Ages 18–70
- Recruiting
Zimmer Biomet Shoulder Arthroplasty PMCF
Zimmer Biomet
- Location
- Golden, CO + 1 other US site
- Eligibility basics
- Ages 20+
- RecruitingHealthy volunteers
Knee Osteoarthritis Rehabilitation Through Rotational Inertia
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 40–70
- RecruitingHealthy volunteers
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers
University of Colorado, Denver
- Location
- Aurora, CO
- Eligibility basics
- Ages 21–85
Who these studies look for
Most require a confirmed diagnosis, often with X-rays or blood tests, and set rules for pain medicines during the study.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.